Literature DB >> 34469647

Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells.

Andrea Lisco1, Amy P Hsu1, Dimana Dimitrova1, Diana M Proctor1, Emily M Mace1, Peiying Ye1, Megan V Anderson1, Stephanie N Hicks1, Christopher Grivas1, Dima A Hammoud1, Maura Manion1, Gabriel J Starrett1, Alvin Farrel1, Kerry Dobbs1, Isaac Brownell1, Christopher Buck1, Luigi D Notarangelo1, Jordan S Orange1, Warren J Leonard1, Michael I Orestes1, Anju T Peters1, Jennifer A Kanakry1, Julia A Segre1, Heidi H Kong1, Irini Sereti1.   

Abstract

Human papillomavirus (HPV) infections underlie a wide spectrum of both benign and malignant epithelial diseases. In this report, we describe the case of a young man who had encephalitis caused by herpes simplex virus during adolescence and currently presented with multiple recurrent skin and mucosal lesions caused by HPV. The patient was found to have a pathogenic germline mutation in the X-linked interleukin-2 receptor subunit gamma gene (IL2RG), which was somatically reverted in T cells but not in natural killer (NK) cells. Allogeneic hematopoietic-cell transplantation led to restoration of NK cytotoxicity, with normalization of the skin microbiome and persistent remission of all HPV-related diseases. NK cytotoxicity appears to play a role in containing HPV colonization and the ensuing HPV-related hyperplastic or dysplastic lesions. (Funded by the National Institutes of Health and the Herbert Irving Comprehensive Cancer Center Flow Cytometry Shared Resources.).
Copyright © 2021 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2021        PMID: 34469647      PMCID: PMC8590529          DOI: 10.1056/NEJMoa2102715

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   176.079


  23 in total

1.  A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers.

Authors:  Sanja Stevanović; Sarah R Helman; John R Wunderlich; Michelle M Langhan; Stacey L Doran; Mei Li M Kwong; Robert P T Somerville; Christopher A Klebanoff; Udai S Kammula; Richard M Sherry; James C Yang; Steven A Rosenberg; Christian S Hinrichs
Journal:  Clin Cancer Res       Date:  2018-12-05       Impact factor: 12.531

2.  Severe cutaneous papillomavirus disease after haematopoietic stem-cell transplantation in patients with severe combined immunodeficiency.

Authors:  H Bobby Gaspar; Catherine Harwood; Irene Leigh; Adrian J Thrasher
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

3.  Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined immunodeficiency.

Authors:  Qurat Ul Ain Kamili; Filiz O Seeborg; Kapil Saxena; Sarah K Nicholas; Pinaki P Banerjee; Laura S Angelo; Emily M Mace; Lisa R Forbes; Caridad Martinez; Teresa S Wright; Jordan S Orange; Imelda Celine Hanson
Journal:  J Allergy Clin Immunol       Date:  2014-08-23       Impact factor: 10.793

Review 4.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

5.  Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency.

Authors:  Caroline Laffort; Françoise Le Deist; Michel Favre; Sophie Caillat-Zucman; Isabelle Radford-Weiss; Marianne Debré; Sylvie Fraitag; Stéphane Blanche; Marina Cavazzana-Calvo; Geneviève de Saint Basile; Jean Pierre de Villartay; Silvia Giliani; Gérard Orth; Jean Laurent Casanova; Christine Bodemer; Alain Fischer
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

6.  Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.

Authors:  Yusuke Okuno; Akihiro Hoshino; Hideki Muramatsu; Nozomu Kawashima; Xinan Wang; Kenichi Yoshida; Taizo Wada; Masaharu Gunji; Tomoko Toma; Tamaki Kato; Yuichi Shiraishi; Atsuko Iwata; Toshinori Hori; Toshiyuki Kitoh; Kenichi Chiba; Hiroko Tanaka; Masashi Sanada; Yoshiyuki Takahashi; Shigeaki Nonoyama; Masafumi Ito; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2015-09-26       Impact factor: 8.317

Review 7.  An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results.

Authors:  John T Schiller; Xavier Castellsagué; Luisa L Villa; Allan Hildesheim
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

8.  CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.

Authors:  Steffen Wagner; Claus Wittekindt; Miriam Reuschenbach; Ben Hennig; Mauran Thevarajah; Nora Würdemann; Elena-Sophie Prigge; Magnus von Knebel Doeberitz; Thomas Dreyer; Stefan Gattenlöhner; Jens Peter Klussmann
Journal:  Int J Cancer       Date:  2016-01-08       Impact factor: 7.396

9.  HPV Vaccination and the Risk of Invasive Cervical Cancer.

Authors:  Jiayao Lei; Alexander Ploner; K Miriam Elfström; Jiangrong Wang; Adam Roth; Fang Fang; Karin Sundström; Joakim Dillner; Pär Sparén
Journal:  N Engl J Med       Date:  2020-10-01       Impact factor: 91.245

10.  Evidence of innate lymphoid cell redundancy in humans.

Authors:  Frédéric Vély; Vincent Barlogis; Blandine Vallentin; Bénédicte Neven; Christelle Piperoglou; Mikael Ebbo; Thibaut Perchet; Maxime Petit; Nadia Yessaad; Fabien Touzot; Julie Bruneau; Nizar Mahlaoui; Nicolas Zucchini; Catherine Farnarier; Gérard Michel; Despina Moshous; Stéphane Blanche; Arnaud Dujardin; Hergen Spits; Jörg H W Distler; Andreas Ramming; Capucine Picard; Rachel Golub; Alain Fischer; Eric Vivier
Journal:  Nat Immunol       Date:  2016-09-12       Impact factor: 25.606

View more
  7 in total

Review 1.  Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, "I Am like a Box of Complexity, You Never Know What You Are Gonna Get".

Authors:  Ehsan Soleymaninejadian; Paola Zelini; Irene Cassaniti; Fausto Baldanti; Mattia Dominoni; Andrea Gritti; Barbara Gardella
Journal:  Vaccines (Basel)       Date:  2022-05-06

Review 2.  Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature.

Authors:  J Zampella; B Cohen
Journal:  Skin Health Dis       Date:  2022-02-09

Review 3.  Exploring the Utility of NK Cells in COVID-19.

Authors:  Xuewen Deng; Hiroshi Terunuma; Mie Nieda
Journal:  Biomedicines       Date:  2022-04-26

4.  Cellular therapies for the treatment and prevention of SARS-CoV-2 infection.

Authors:  Susan R Conway; Michael D Keller; Catherine M Bollard
Journal:  Blood       Date:  2022-07-21       Impact factor: 25.476

5.  Case Report: Altered NK Cell Compartment and Reduced CXCR4 Chemotactic Response of B Lymphocytes in an Immunodeficient Patient With HPV-Related Disease.

Authors:  Margherita Doria; Giusella M F Moscato; Silvia Di Cesare; Gigliola Di Matteo; Mayla Sgrulletti; Françoise Bachelerie; Viviana Marin-Esteban; Viviana Moschese
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

6.  A TCR mimic monoclonal antibody for the HPV-16 E7-epitope p11-19/HLA-A*02:01 complex.

Authors:  Tao Dao; Sungsoo Mun; Tatyana Korontsvit; Abdul G Khan; Mary Ann Pohl; Thomas White; Martin G Klatt; David Andrew; Ivo C Lorenz; David A Scheinberg
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

7.  T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation.

Authors:  Janine E Melsen; Monique M van Ostaijen-Ten Dam; Erik B van den Akker; Marij J P Welters; Kim C Heezen; Ingrid Pico-Knijnenburg; P Martijn Kolijn; Robbert G M Bredius; Remco van Doorn; Anton W Langerak; Marco W Schilham; Arjan C Lankester
Journal:  J Clin Immunol       Date:  2022-05-09       Impact factor: 8.542

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.